midazolam has been researched along with Agnosia in 2 studies
Midazolam: A short-acting hypnotic-sedative drug with anxiolytic and amnestic properties. It is used in dentistry, cardiac surgery, endoscopic procedures, as preanesthetic medication, and as an adjunct to local anesthesia. The short duration and cardiorespiratory stability makes it useful in poor-risk, elderly, and cardiac patients. It is water-soluble at pH less than 4 and lipid-soluble at physiological pH.
midazolam : An imidazobenzodiazepine that is 4H-imidazo[1,5-a][1,4]benzodiazepine which is substituted by a methyl, 2-fluorophenyl and chloro groups at positions 1, 6 and 8, respectively.
Agnosia: Loss of the ability to comprehend the meaning or recognize the importance of various forms of stimulation that cannot be attributed to impairment of a primary sensory modality. Tactile agnosia is characterized by an inability to perceive the shape and nature of an object by touch alone, despite unimpaired sensation to light touch, position, and other primary sensory modalities.
| Excerpt | Relevance | Reference |
|---|---|---|
| " We present the case of a healthy 12-year-old girl who received preoperative midazolam with the desired anxiolytic effect, underwent a brief general anesthetic, and then exhibited postoperative delirium, consisting of a transient associative agnosia and expressive aphasia." | 7.81 | Emergence delirium with transient associative agnosia and expressive aphasia reversed by flumazenil in a pediatric patient. ( Cook-Sather, SD; DiPuppo, PM; Drobish, JK; Kelz, MB, 2015) |
| " We present the case of a healthy 12-year-old girl who received preoperative midazolam with the desired anxiolytic effect, underwent a brief general anesthetic, and then exhibited postoperative delirium, consisting of a transient associative agnosia and expressive aphasia." | 3.81 | Emergence delirium with transient associative agnosia and expressive aphasia reversed by flumazenil in a pediatric patient. ( Cook-Sather, SD; DiPuppo, PM; Drobish, JK; Kelz, MB, 2015) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Mohan, AM | 1 |
| Sharma, A | 1 |
| Goyal, S | 1 |
| Kothari, N | 1 |
| Vyas, R | 1 |
| Goel, AD | 1 |
| Sethi, P | 1 |
| Kumari, K | 1 |
| Bhatia, P | 1 |
| Drobish, JK | 1 |
| Kelz, MB | 1 |
| DiPuppo, PM | 1 |
| Cook-Sather, SD | 1 |
1 trial available for midazolam and Agnosia
| Article | Year |
|---|---|
Comparison of Caudal Dexmedetomidine and Midazolam as an Adjuvant to Ropivacaine for Postoperative Pain Relief in Children Undergoing Infra-Umbilical Surgeries: A Randomized Controlled Trial.
Topics: Adjuvants, Immunologic; Adjuvants, Pharmaceutic; Agnosia; Child; Child, Preschool; Dexmedetomidine; | 2023 |
1 other study available for midazolam and Agnosia
| Article | Year |
|---|---|
Emergence delirium with transient associative agnosia and expressive aphasia reversed by flumazenil in a pediatric patient.
Topics: Adjuvants, Anesthesia; Agnosia; Anesthesia, General; Aphasia, Broca; Child; Delirium; Female; Flumaz | 2015 |